We are excited to announce a significant enhancement to our latest product, GO2SLEEP 3, through a collaborative effort with Actxa Pte Ltd, Singapore. This collaboration has enabled us to integrate their cutting-edge Non-invasive Blood Glucose Monitoring technology into Go2sleep 3. This integration ensures not only high accuracy but also enhances the overall user experience in blood glucose monitoring.

The incorporation of Actxa’s advanced technology into GO2SLEEP 3 represents a milestone in our commitment to innovation and user-centric design. By leveraging their expertise, we aim to provide users with a seamless and reliable method for monitoring blood glucose levels, directly from a wearable device. This development underscores our dedication to improving health monitoring technologies and empowering individuals to manage their health more effectively.

As we continue to refine GO2SLEEP 3, we are confident that this integration will establish a new benchmark in wearable health technology, providing users with unprecedented convenience and precision in managing their health metrics.

For more detailed information on the accuracy and the supporting documentation of this technology, please refer to the following link: